Telomere attrition and Chk2 activation in human heart failure

被引:143
作者
Oh, H
Wang, SC
Prahash, A
Sano, M
Moravec, CS
Taffett, GE
Michael, LH
Youker, KA
Entman, ML
Schneider, MD [1 ]
机构
[1] Baylor Coll Med, Ctr Cardiovasc Dev, Houston, TX 77030 USA
[2] Baylor Coll Med, Methodist Hosp, DeBakey Heart Ctr, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[5] Baylor Coll Med, Dept Physiol & Mol Biophys, Houston, TX 77030 USA
[6] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
关键词
D O I
10.1073/pnas.0836098100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The "postmitotic" phenotype in adult cardiac muscle exhibits similarities to replicative senescence more generally and constitutes a barrier to effective restorative growth in heart disease. Telomere dysfunction is implicated in senescence and apoptotic signaling but its potential role in heart disorders is unknown. Here, we report that cardiac apoptosis in human heart failure is associated specifically with defective expression of the telomere repeat-binding factor TRF2, telomere shortening, and activation of the DNA damage checkpoint kinase, Chk2. In cultured cardiomyocytes, interference With either TRF2 function or expression triggered telomere erosion and apoptosis, indicating that cell death can occur via this pathway even in postmitotic, noncycling cells; conversely, exogenous TRF2 conferred protection from oxidative stress. In vivo, mechanical stress was sufficient to down-regulate TRF2, shorten telomeres, and activate Chk2 in mouse myocardium, and transgenic expression of telomerase reverse transcriptase conferred protection from all three responses. Together, these data suggest that apoptosis in chronic heart failure is mediated in part by telomere dysfunction and suggest an essential role for TRF2 even in postmitotic cells.
引用
收藏
页码:5378 / 5383
页数:6
相关论文
共 41 条
  • [1] E1A can provoke G1 exit that is refractory to p21 and independent of activating Cdk2
    Akli, S
    Zhan, S
    Abdellatif, M
    Schneider, MD
    [J]. CIRCULATION RESEARCH, 1999, 85 (04) : 319 - 328
  • [2] Switching and signaling at the telomere
    Blackburn, EH
    [J]. CELL, 2001, 106 (06) : 661 - 673
  • [3] FUNCTIONAL-CHARACTERIZATION AND DEVELOPMENTAL REGULATION OF MOUSE TELOMERASE RNA
    BLASCO, MA
    FUNK, W
    VILLEPONTEAU, B
    GREIDER, CW
    [J]. SCIENCE, 1995, 269 (5228) : 1267 - 1270
  • [4] Telomerase extracurricular activities
    Chang, S
    DePinho, RA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) : 12520 - 12522
  • [5] TELOMERE SHORTENING ASSOCIATED WITH CHROMOSOME INSTABILITY IS ARRESTED IN IMMORTAL CELLS WHICH EXPRESS TELOMERASE ACTIVITY
    COUNTER, CM
    AVILION, AA
    LEFEUVRE, CE
    STEWART, NG
    GREIDER, CW
    HARLEY, CB
    BACCHETTI, S
    [J]. EMBO JOURNAL, 1992, 11 (05) : 1921 - 1929
  • [6] Protection of mammalian telomeres
    de Lange, T
    [J]. ONCOGENE, 2002, 21 (04) : 532 - 540
  • [7] Left ventricular hypertrophy in ascending aortic stenosis mice - Anoikis and the progression to early failure
    Ding, B
    Price, RL
    Goldsmith, EC
    Borg, TK
    Yan, XH
    Douglas, PS
    Weinberg, EO
    Bartunek, J
    Thielen, T
    Didenko, VV
    Lorell, BH
    [J]. CIRCULATION, 2000, 101 (24) : 2854 - 2862
  • [8] Cardiac hypertrophy: The good, the bad and the ugly
    Frey, N
    Olson, EN
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 2003, 65 : 45 - 79
  • [9] Grepin C, 1997, DEVELOPMENT, V124, P2387
  • [10] Mammalian telomeres end in a large duplex loop
    Griffith, JD
    Comeau, L
    Rosenfield, S
    Stansel, RM
    Bianchi, A
    Moss, H
    de Lange, T
    [J]. CELL, 1999, 97 (04) : 503 - 514